- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07599436
Laughter Yoga and Sleep Hygiene Training for College Students With Premenstrual Syndrome (LYSHPMS)
14. maj 2026 opdateret af: Şengül Yaman Sözbir, Gazi University
The Effect of Laughter Yoga and Sleep Hygiene Training on Premenstrual Syndrome Levels, Perceived Stress Levels, and Sleep Quality Among University Students
This study aims to evaluate the effects of laughter yoga and sleep hygiene training on premenstrual syndrome (PMS) symptoms, perceived stress levels, and sleep quality among nursing students.Premenstrual syndrome is a common health issue characterized by physical symptoms as well as emotional fluctuations, anxiety, depressive mood, and behavioral changes, which can negatively impact quality of life.
Additionally, it is known that stress is a significant risk factor that exacerbates PMS symptoms, and that healthy lifestyle behaviors may be effective in alleviating these symptoms.
In this context, it has been reported that yoga and similar relaxation-based practices support mental well-being by reducing stress levels.The intervention consists of laughter yoga and sleep hygiene education, implemented as non-pharmacological methods over a 4-week period.Participants were assessed at baseline, immediately following the intervention, and during the 1-month follow-up period.
The primary objective is to observe improved sleep quality alongside reductions in PMS symptoms and stress levels in participants as a result of the intervention.
The findings are expected to contribute to the effectiveness of non-pharmacological, low-cost, and feasible approaches in managing PMS symptoms, as well as addressing stress and sleep quality.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Premenstrual syndrome (PMS) is a common health issue characterized by emotional fluctuations, anxiety, depressive mood, and behavioral changes, in addition to physical symptoms that can negatively impact quality of life.
PMS can lead to a decline in quality of life by negatively affecting an individual's social life, psychological well-being, emotional balance, and dietary habits; in some individuals, it can develop into a severe condition that significantly restricts daily life.
Within the multifaceted nature of PMS, stress emerges as a significant risk factor; it is noted that stress can increase symptom severity, elevate the frequency of traumatic life experiences, and underlie sleep disturbances in individuals.
Deterioration in sleep quality further exacerbates this process, being associated with fatigue, emotional fluctuations, and a decline in overall well-being.
While non-pharmacological methods are used to mitigate or prevent these effects on the individual, laughter yoga-based interventions remain limited.
This study evaluates laughter yoga-a low-cost, feasible non-pharmacological method that incorporates simulated laughter, rhythmic breathing, gentle movements, and meditation-examining its effects on PMS management, stress-related hormone (cortisol) levels, and sleep quality.The intervention consisted of laughter yoga and sleep hygiene training administered over a 4-week period.
Sleep hygiene training was provided during the first session of laughter yoga.
Participants were assessed at different time points: at baseline, immediately following the intervention, and at the 1-month follow-up.
The primary objective of the study is to assess changes in PMS levels, stress, and sleep quality over time among university students and to determine the sustainability of the intervention's effects during the follow-up period.
This study contributes to the literature on nonpharmacological methods used to evaluate the effectiveness of interventions on PMS levels, stress, and sleep quality.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
45
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ankara
-
Ankara, Ankara, Tyrkiet (Türkiye), 06000
- Gazi University Institute of Health Sciences
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion criteria for the study:
- Female, 18 years of age or older
- Second-year nursing student (who has not yet taken the Women's Health and Diseases Nursing course)
- Having a regular menstrual cycle
- Scoring 45 or higher on the Premenstrual Syndrome Scale (PMS level is mild)
- Using the WhatsApp® app
Exclusion criteria for the study:
- Having any communication difficulties (mental, auditory, visual, etc.)
- Having previously participated in a stress management program
- Using pharmacological or non-pharmacological methods to manage PMS symptoms
- Having a chronic or neuropsychiatric condition
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Participants were enrolled in a 4-week laughter yoga program.They received training on sleep hygiene
intervention group
|
University students participated in 45-minute laughter yoga sessions held once a week for four weeks.
During the first session, participants received training on sleep hygiene and were given a brochure on the topic.
The sleep hygiene training covered the following topics: sleep, the importance of sleep, factors affecting sleep (circadian rhythm, sleep-wake cycle, nutrition, physical activity), factors causing poor sleep, sleep deprivation, and sleep hygiene.
|
|
Ingen indgriben: No interventions were made regarding the participants.
control grup
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in premenstrual syndrome levels
Tidsramme: Baseline, 4 weeks (end of intervention), 1-month follow-up
|
PMS levels and associated physical, emotional, and behavioral changes in participants were measured using a validated scale.
Changes in PMS levels were assessed by comparing the intervention and control groups.The Premenstrual Syndrome Scale (PSS) was used to evaluate the data.The scale consists of a total of 44 items and 9 subscales, organized on a 5-point Likert scale.
The scale is scored as follows: 1 = never, 2 = rarely, 3 = sometimes, 4 = often, and 5 = always.
Scores obtained from the scale can be calculated separately for each subscale or evaluated based on the total score.
The total scale score ranges from 44 to 220, and the presence of PMS is considered in individuals scoring 132 or higher.
Additionally, the severity of PMS is classified as follows: 44 points = no PMS, 45-103 points = mild PMS, 104-163 points = moderate PMS, and 164-220 points = severe PMS.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in perceived stress levels
Tidsramme: Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Participants' perceived stress levels were measured using a validated scale.
Changes in stress levels were assessed by comparing the intervention and control groups.
The Perceived Stress Scale (PSS) was used to analyze the data.The scale consists of a total of 14 items, each of which is rated on a 5-point Likert scale (0 = Never, 4 = Very often).
The scale consists of two subscales: low self-efficacy perception (items 4, 5, 6, 8, 9, 10, 13) and stress/distress perception (items 1, 2, 3, 7, 11, 12, 14).
Items 4, 5, 6, 7, 9, 10, and 13 are reverse-scored.
The lowest and highest possible scores a participant can achieve on this scale are 0 and 56, respectively.
An increase in the total score from the scale or its subscales indicates an increase in the individual's perceived stress level.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
|
Changes in sleep quality
Tidsramme: Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Participants' sleep quality was measured using a validated scale.
Changes in sleep quality were assessed by comparing the intervention and control groups.
The assessment was conducted using the Pittsburgh Sleep Quality Index (PSQI).
The scale consists of 24 questions.
The first 18 questions, which the participant answers themselves, are used to calculate the total score and the subscale scores.
The 18 questions on the scale cover 7 components: sleep quality (component 1), sleep latency (component 2), sleep duration (component 3), habitual sleep efficiency (component 4), sleep disorder (component 5), sleep medication use (component 6), and daytime sleep dysfunction (component 7).
Each component is scored on a scale of 0-3.
The sum of these 7 component scores yields the total score.
The total score ranges from 0 to 21.
Individuals with a score of 5 or below are assessed as having "good" sleep quality, while those with a score above 5 are assessed as having "poor" sleep quality.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Şengül YAMAN SÖZBİR, Gazi University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. marts 2026
Primær færdiggørelse (Faktiske)
1. maj 2026
Studieafslutning (Faktiske)
1. maj 2026
Datoer for studieregistrering
Først indsendt
4. maj 2026
Først indsendt, der opfyldte QC-kriterier
14. maj 2026
Først opslået (Faktiske)
20. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
20. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i nervesystemet
- Psykiske lidelser
- Patologiske processer
- Søvnvågningsforstyrrelser
- Søvnforstyrrelser, iboende
- Dyssomnier
- Menstruationsforstyrrelser
- Patologiske tilstande, tegn og symptomer
- Opførsel
- Sundhedsadfærd
- Søvninitiering og vedligeholdelsesforstyrrelser
- Præmenstruelt syndrom
- Søvnhygiejne
- Terapeutik
- Patientpleje
- Sundhedstjenester
- Sundhedsfaciliteter Arbejdsstyrke og tjenester
- Palliativ pleje
Andre undersøgelses-id-numre
- EBS
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Data confidentiality and participant privacy will be strictly protected in accordance with applicable laws and regulations.
Individual participant data (IPD) will not be shared.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Supportive Care
-
Sunnybrook Health Sciences CentreAfsluttet
-
Xuanwu Hospital, BeijingBioray LaboratoriesIkke rekrutterer endnuMultipel sclerose | Neuromyelitis Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserende polyradiculoneuropati | Myasthenia Gravis, generaliseretKina
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterende
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterendeSikkerhed og effektivitet af cellulære lægemidler, objektiv responsrate for forsøgspersoner osvKina
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAfsluttetRefraktært diffust stort B-cellet lymfomKina
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.RekrutteringKlinisk forsøg med autologe GPC3 CAR-T-celler (CBG166) terapi for avanceret hepatocellulært karcinomAvanceret hepatocellulært karcinomKina
-
Nexcella Inc.Immix Biopharma, Inc.RekrutteringLet kæde (AL) amyloidoseForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRecidiverende og refraktær B-celle lymfomKina
-
Second Affiliated Hospital, School of Medicine,...Rekruttering
-
University of California, San FranciscoTrukket tilbageLymfom | Leukæmi | Plasmacelledyskrasi